Vaccitech Renames as Barinthus Biotherapeutics to Highlight
New Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data OXFORD, United Kingdom, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Barinthus...
Source: globenewswire.com
Repeat Dosing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Repeat Dosing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Repeat Dosing Today - Breaking & Trending Today
Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its...
Source: marketscreener.com
Hansa Biopharma announces encouraging high-level results for first-in-human trial of HNSA-5487
LUND, Sweden, Oct. 9, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in...
Source: europapress.es
Hansa Biopharma announces encouraging high-level results for first-in-human trial of HNSA-5487
HNSA-5487 is a next-generation IgG-cleaving enzyme and the lead candidate in the NiceR development program Lund, Sweden, October 9, 2023. Hansa Biopharma, Hansa , a pioneer in enzyme technology for...
Source: marketscreener.com
Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients
– PRGN-3005 was well-tolerated with no dose limiting toxicities, no CRS greater than Grade 2, and no neurotoxicity – – PRGN-3005 cells demonstrated expansion...
Source: prnewswire.com